{"rows":[{"id":2310,"title":"[Psychedelics in the treatment of PTSD].","authors":"Vermetten E, Krediet E, Bostoen T, Breeksema JJ, Schoevers RA, van den Brink W","journal":"Tijdschrift voor psychiatrie","publication_date":"2020-01-01","publication_year":2020,"doi":null,"pubmed_id":"32816292","openalex_id":"https://openalex.org/W3080697786","source_url":"https://pubmed.ncbi.nlm.nih.gov/32816292/","substance_tags":"psilocybin","topic_tags":"PTSD,Mechanism of Action,Randomized Controlled Trial,Review Article","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:34:29","bibtex":null,"source_record_id":"PMID:32816292","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32816292/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32816292","source_url":"https://pubmed.ncbi.nlm.nih.gov/32816292/","doi":"","pmid":"32816292","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2309,"title":"[Psychedelics for existential distress in terminally ill patients].","authors":"Schimmel N, Breeksema JJ, Veraart JKE, van den Brink W, Schoevers RA","journal":"Tijdschrift voor psychiatrie","publication_date":"2020-01-01","publication_year":2020,"doi":null,"pubmed_id":"32816294","openalex_id":"https://openalex.org/W3080105950","source_url":"https://pubmed.ncbi.nlm.nih.gov/32816294/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:34:29","bibtex":null,"source_record_id":"PMID:32816294","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32816294/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32816294","source_url":"https://pubmed.ncbi.nlm.nih.gov/32816294/","doi":"","pmid":"32816294","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2308,"title":"[Microdosing with psychedelics: what do we know?].","authors":"Kuypers KPC","journal":"Tijdschrift voor psychiatrie","publication_date":"2020-01-01","publication_year":2020,"doi":null,"pubmed_id":"32816295","openalex_id":"https://openalex.org/W3081065706","source_url":"https://pubmed.ncbi.nlm.nih.gov/32816295/","substance_tags":"psilocybin","topic_tags":"Microdosing,Wellbeing,Emotional Processing","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:34:29","bibtex":null,"source_record_id":"PMID:32816295","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32816295/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32816295","source_url":"https://pubmed.ncbi.nlm.nih.gov/32816295/","doi":"","pmid":"32816295","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":3,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Tijdschrift voor psychiatrie","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}